Daily as of 3 Nov 16:00 ET
- Price
- between the two $61.71 vs 50 $62.61 / 200 $60.01
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 29 Dec 2025 · projected 30 bars out
BMY | Bristol-Myers Squibb Co.NYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$61.71
-$1.31 (-2.08%)
Bristol-Myers Squibb Co. (BMY) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Dec 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $62.48 vs 50 $58.83 / 200 $55.47
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 31 Aug 2026 · projected 30 bars out · tested 1 bar
4-hour as of 3 Nov 16:00 ET
- Price
- above both $61.71 vs 50 $60.55 / 200 $61.68
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 bar 2 · projected 25 bars out · tested 5 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death | 4-hour | 25 bars out | 5 bar cross test |
| week of 31 Aug 2026 | 🟨Golden moderate | weekly | 30 bars out | 1 bar cross test |
| 27 Jul 2026 | 🟨Golden | 4-hour | 23 bars out | Not tested |
| 14 May 2026 | 💀Death | 4-hour | 20 bars out | 3 bar cross test |
| 29 Dec 2025 | 🟨Golden steep | daily | 30 bars out | Not tested |
About BMY
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$619M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge